These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 1653048

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patients.
    Gatanaga T, Lentz R, Masunaka I, Tomich J, Jeffes EW, Baird M, Granger GA.
    Lymphokine Res; 1990; 9(2):225-9. PubMed ID: 2187118
    [Abstract] [Full Text] [Related]

  • 4. Release of soluble TNF/LT receptors from a human ovarian tumor cell line (PA-1) by stimulation with cytokines in vitro.
    Gatanaga M, Grosen EA, Burger RA, Granger GA, Gatanaga T.
    Lymphokine Cytokine Res; 1993 Aug; 12(4):249-53. PubMed ID: 8218597
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
    Wu S, Boyer CM, Whitaker RS, Berchuck A, Wiener JR, Weinberg JB, Bast RC.
    Cancer Res; 1993 Apr 15; 53(8):1939-44. PubMed ID: 8385577
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Resistance to the cytolytic action of lymphotoxin and tumor necrosis factor coincides with the presence of gap junctions uniting target cells.
    Fletcher WH, Shiu WW, Ishida TA, Haviland DL, Ware CF.
    J Immunol; 1987 Aug 01; 139(3):956-62. PubMed ID: 3110292
    [Abstract] [Full Text] [Related]

  • 8. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
    Abe Y, Gatanaga M, Osuka Y, Kimura S, Burger RA, Granger GA, Gatanaga T.
    J Immunol; 1993 Jun 01; 150(11):5070-9. PubMed ID: 8098725
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS, Berger AE, Ware CF.
    J Immunol; 1990 Apr 01; 144(7):2582-91. PubMed ID: 1969453
    [Abstract] [Full Text] [Related]

  • 10. Comparison of TNFalpha and TNFbeta cytolytic mechanisms in human ovarian and cervical carcinoma cell lines.
    Powell CB, Scott JH, Collins JL.
    Gynecol Oncol; 1998 Nov 01; 71(2):258-65. PubMed ID: 9826469
    [Abstract] [Full Text] [Related]

  • 11. Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor.
    Schmid DS, Hornung R, McGrath KM, Paul N, Ruddle NH.
    Lymphokine Res; 1987 Nov 01; 6(3):195-202. PubMed ID: 3498099
    [Abstract] [Full Text] [Related]

  • 12. Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy.
    Grosen EA, Granger GA, Gatanaga M, Ininns EK, Hwang C, DiSaia P, Berman M, Manetta A, Emma D, Gatanaga T.
    Gynecol Oncol; 1993 Jul 01; 50(1):68-77. PubMed ID: 8394276
    [Abstract] [Full Text] [Related]

  • 13. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.
    Kost ER, Mutch DG, Herzog TJ.
    Gynecol Oncol; 1999 Mar 01; 72(3):392-401. PubMed ID: 10053112
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K, Bienvenu J, Coiffier B, Salles G.
    Eur Cytokine Netw; 1995 Mar 01; 6(2):83-96. PubMed ID: 7578992
    [Abstract] [Full Text] [Related]

  • 15. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
    Granger GA, Masunaka I, Averbook B, Kobayashi M, Fitzgerald M, Yamamoto R.
    J Biol Response Mod; 1988 Oct 01; 7(5):488-97. PubMed ID: 3263472
    [Abstract] [Full Text] [Related]

  • 16. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE, Scallon BJ, Trinh H, Chernajovsky Y, Ghrayeb J, Feldmann M.
    Eur Cytokine Netw; 1998 Sep 01; 9(3):255-62. PubMed ID: 9831174
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro.
    Dett CA, Gatanaga M, Ininns EK, Cappuccini F, Yamamoto RS, Granger GA, Gatanaga T.
    J Immunol; 1991 Mar 01; 146(5):1522-6. PubMed ID: 1847164
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (Matrigel) with concomitant induction of 92 kDa gelatinase secretion.
    Kubota S, Takeda K, Yamada T, Nomura Y, Takeda M, Iwamoto S, Seyama Y.
    Cancer Lett; 1996 Jan 02; 98(2):233-40. PubMed ID: 8556714
    [Abstract] [Full Text] [Related]

  • 19. Lymphotoxin lacks effects on 75-kDa receptors in cytotoxicity on U-937 cells.
    Iwamoto S, Shibuya I, Takeda K, Takeda M.
    Biochem Biophys Res Commun; 1994 Feb 28; 199(1):70-7. PubMed ID: 8123048
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: phospholipase activation and deacylation of specific-membrane phospholipids.
    Knauer MF, Longmuir KJ, Yamamoto RS, Fitzgerald TP, Granger GA.
    J Cell Physiol; 1990 Mar 28; 142(3):469-79. PubMed ID: 2107184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.